The promyelocytic leukemia protein PML is a tumor and growth suppressor and plays an important role in a multiple pathways of apoptosis and regulation of cell cycle progression. Our previous studies and others also documented a role of PML in transcriptional regulation through its association with transcription coactivator CBP and transcription corepressor HDAC. Here, we showed that PML is a potent transcriptional repressor of Nur77, an orphan receptor and a member of the steroid receptor superfamily of proteins. We found that PML represses Nur77-mediated transactivation through a physical and functional interaction between the two proteins. PML interacts with Nur-77 in vitro in a GSTpull down assay and in vivo by coimmunoprecipitation assay. PML/Nur77 colocalized in vivo in a double immuno¯uorescent staining and confocal microscopic analysis. Our study further showed that the coiled ± coil domain of PML interacts with the DNA-binding domain of Nur77 (amino acids 267 ± 332). Electrophoretic mobility shift assay demonstrated that PML interferes with Nur77 DNA binding in a dose-dependent manner. This study indicates that PML interacts with the DNAbinding domain of Nur77 and represses transcription by preventing it from binding to the target promoter. This study supports a role of PML/Nur77 interaction in regulating cell growth and apoptosis.
Introduction
The promyelocytic leukemia, PML gene was originally cloned and characterized for its involvement in t(15;17), the chromosomal translocation consistently found in patients with acute promyelocytic leukemia. This translocation led to the creation of the fusion genes encoding the PML-retinoic acid receptor (RAR)a and RARa-PML fusion proteins (reviewed in Melnick and Licht, 1999) .
It is well documented that PML suppresses cell growth (Mu et al., 1994; Liu et al., 1995; Le et al., 1998; Wang et al., 1998) and acts as a tumor suppressor in vivo (Guo et al., 2000) . PML associates with transcriptional coactivator and corepressor Wu et al., 2001 ) supporting a role of PML in regulating gene expression. PML interacts with the transcription coactivator CBP and colocalized in the PML NB (LaMorte et al., 1998; Zhong et al., 1999 , Boisvert et al., 2001 . Interestingly, the acetylated or the transcriptional active forms of the chromatin are associated with the PML NB (Boisvert et al., 2000) . A role of PML in transcription activation is supported by the ®ndings that PML activates Fos-mediated transcription of AP-1 (Vallian et al., 1998a) and it also interacts with tumor suppressor p53 and GATA-2 leading to activation transcription of their target genes (Pearson et al., 2000; Ferbeyre et al., 2000; Tsuzuki et al., 2000) . On the other hand, PML can also act as a transcriptional repressor when fused with the DNA-binding domain of Ga14, it represses Ga14 mediated transcription through a mechanism by recruiting HDACs to the target promoter (Wu et al., 2001) . PML also inhibits Sp1-mediated transactivation of the epidermal growth factor (EGF) receptor promoter (Vallian et al., 1998b) and inhibits transcription activation mediated by Tax and Daxx (Li et al., 2000b; . PML has also been shown to interact with multiple corepressors and mediate transcriptional repression function of Mad (Khan et al., 2001) .
PML is the essential component of the PML NB. No NB could be found in PML 7/7 cells and the NB associated proteins such as SP100, Daxx, and BLM exhibit a nuclear diuse staining pattern in these cells (Ishov et al., 1999; Zhong et al., 2000) . PML is normally modi®ed at three dierent sites of lysine residues by the ubiquitin-related protein SUMO-1 (Kamitani et al., 1998; Duprez et al., 1999) . This modi®cation is required for the assembly of the PML NB. Replacement of these lysine residues interferes with the formation of PML NB. It is not clear how SUMO-1 modi®cation of PML aects its function in growth suppression, transcriptional regulation and apoptosis. However, Le et al. (1996) reported that PML mutants unable to form PML NB were unable to suppressed cell growth and transformation. It appears that SUMO-1 regulates the structural integrity of PML NB and to maintain this NB structure that enhance the stability of the associated protein factors.
Nur77 is an orphan receptor and a member of the steroid/thyroid hormone family of receptor proteins (Hazel et al., 1988; Milbrandt, 1988) that is induced rapidly in response to growth factors or phorbol ester in quiescent ®broblasts (Hazel et al., 1988; Nakai et al., 1990; Herschman, 1991) . Nur77 is a potent transcription activator involved in regulation of cellular responses to growth factors by activating its target genes (Wilson et al., 1993) . Nur77 also plays a key role in apoptosis of T lymphocytes and various cell types. This protein is induced rapidly during apoptosis of immature lymphocytes (Woronicz et al., 1994) . In prostate cancer cell lines, treatment with various apoptosis-inducing agents rapidly induced Nur77 expression (Uemura and Chang, 1998) . In addition, overexpression of a dominant-negative inhibitor of Nur77 inhibits apoptosis . A recent study demonstrated that Nur77 translocates from the nucleus to the mitochondria in response to apoptotic stimulus, where it induced apoptosis through a mechanism involving the release of cytochrome c (Li et al., 2000a) . The apoptosis-inducing function of Nur77 in this case is independent of its ability to activate transcription of target genes.
Our previous study demonstrated that PML interacts with Sp1 and represses the transactivation of Sp1-dependent EGF-receptor promoter (Vallian et al., 1998b) . We also showed that PML acts as a transcription repressor by recruiting corepressor histone deacetylases when fused to the GAL4 DNA binding domain in a GAL4 responsive promoter Wu et al., 2001b) . Here, we demonstrate that PML interacts with the DNA binding domain of Nur77, inhibits its binding to a DNA target and signi®cantly represses its transactivation activity. Our study further shows that Nur77 is recruited to the PML NB in a transient transfection assay, and the two proteins are colocalized at the endogenous levels in vivo.
Results

Dose-dependent PML-induced inhibition of Nur77 transactivation of NurRE
To investigate the eect of PML on the transactivation of the NurRE, the (NurRE)3-tk-Luc construct, containing three copies of NurRE, was subcloned into the pGL3 vector to create the reporter plasmid pGL3(NurRE)3-tk-Luc. This reporter plasmid was used in a series of transient transfection assays in U2OS cells. The results presented in Figure 1a demonstrated that, compared with controls, pRC/ Nur77 signi®cantly activated the transcription of the reporter gene. However, when the PML expression vector pCDNA3/PML was cotransfected, the Nur77-mediated luciferase activity was signi®cantly lower than that in controls. Moreover, PML inhibited reporter activity in a dose-dependent manner. Cotransfection of 200 ng of pCDNA3/PML decreased the reporter activity to a level 10 times lower than that in the control (Figure 1a ). To rule out the possibility that the repression eect is a result of PML inhibition of Nur77 expression, a Western blot analysis was performed. Result of this study shows that PML did not aect the expression level of the Nur77 protein. This study demonstrated that PML is a transcriptional repressor of Nur77-mediated transcription of NurRE. In a similar cotransfection experiment shown in Figure 1b , PML was found to induce a moderate increase in E2F1-mediated transactivation indicating that PML represses Nur77-mediated transcription of NurRE is speci®c. 
Physical interaction between PML and Nur77
To understand further how PML represses transactivation mediated by Nur77, we ®rst examine whether the two proteins are associated in vivo by coimmunoprecipitation assay. Nuclear extracts were isolated from 293T cells cotransfected with pCruz-HA-Nur77 and pCDNA3/PML. The coimmunoprecipitation assay was performed using either PML or HA-speci®c antibodies. Neither protein could be precipitated by nonspeci®c preimmune serum ( Figure 2a) ; therefore, coprecipitation of Nur77 by anti-PML antibody was speci®c. To study the interaction further, we cloned PML and Nur77 cDNA into pGSTag vector. The GSTag-PML or GSTag-Nur77 fusion protein was immobilized on glutathione agarose beads and mixed with the in vitrotranslated 35 S-labeled Nur77 or PML. The results presented in Figure 2b demonstrated that PML bound speci®cally to Nur77 but not to the control GST beads. This study strongly suggests a physical interaction between PML and Nur77 in vitro.
Interaction of PML with Nur77 through specific domains
To determine which domain of PML is employed in the interaction with Nur77, we designed and prepared a series of PML and Nur77 deletion mutants and used GST-pull down assays to assess the ability of these mutants to interact with PML/Nur77. The results presented in Figure 3b ,c showed that mutants PML(96 ± 633) and PML(1 ± 555) bind strongly to the in vitro translated Nur77 protein. Mutants PML1 ± 303 and PML331 ± 633 bind Nur77 with low anity and that PMLDdim (aa 276 ± 343) did not bind Nur77. This study demonstrated that the coiled ± coil domain of PML (aa 233 ± 360), which is responsible for homodimerization (Kastner et al., 1992) , was involved in the speci®c interaction with Nur77. Similar GST-pull down assays was performed using the GST-Nur77 mutants and the in vitro translated PML protein. Results presented in Figure 3d ,e showed that mutants Nur77(1 ± 275) and Nur77(330 ± 598) did not bind PML but mutants Nur77(1 ± 345) and Nur77(260 ± 598) bind strongly to PML in the GST-pull down assay. This result demonstrated that the region between amino acids 260 ± 330, a region previously shown to be the DNA-binding domain of Nur77 (see review by Enmark and Gustafssan, 1996) is responsible for interaction with PML.
To gain further insight into the functional signi®-cance of this interaction, we transiently transfected the Nur77 responsive element-reporter construct pGL3(NurRE)3-tk-Luc into U2OS cells. Cotransfection of Nur77 with wild-type PML, PML(1 ± 447), PML(1 ± 555) expression plasmids reduced Nur77-dependent transactivation of reporter activity to a level 10 times lower than that seen in controls. Such a transcriptional repression eect was not seen upon cotransfected with PML(1 ± 216), PML(447 ± 555), or PML(555 ± 633) expression plasmids ( Figure 4 ). These results are consistent with the GST-pull down assay results presented in Figure 3c and further demonstrate that PML inhibits Nur77-mediated transactivation through the coiled ± coil dimerization domain.
PML inhibits binding of Nur77 to NurRE
To investigate whether PML represses Nur77-mediated transcription of NurRE by competing for binding to the DNA elements, gel retardation assays were performed using the 32 P-labeled oligonucleotide of NurRE. This study showed that PML does not bind to NurRE (data not shown), suggesting that PML inhibits Nur77-mediated transactivation of NurRE through a mechanism independent of a PML/NurRE interaction. In fact, the results suggest that PML exerts its eects by preventing Nur77 from binding to NurRE. To explore this possibility, we examined the eect of PML on the binding of Nur77 to NurRE. Nur77 formed a strong complex with the NurRE (Figure 5 ), a ®nding consistent with that in the previous report. However, the amount of Nur77-NurRE bound complex was signi®cantly lower after the in vitro translated PML protein was added. This inhibitory eect was dramatically enhanced when a three molar excess of PML protein was included in the assay ( Figure 5 ). This result strongly suggests that S-labeled in vitro-translated Nur77 or PML proteins were used in the pull-down assay PML interacts with Nur77, resulting in the formation of PML/Nur77 heterodimers that fail to bind to NurRE.
Nur77 colocalizes with PML in nuclear bodies
Nur77 is localized mainly in the nucleus, in a nucleardiused staining pattern. In many cell lines, Nur77 is also found in the cytoplasm. Our study presented above demonstrated that PML is a transcriptional repressor of Nur77-mediated transactivation. It is thus possible that PML inhibits transactivation of Nur77 by functionally association between the two proteins. We sought to determine whether Nur77 is associated with PML in the PML NB in vivo. The expression plasmid, pCruz/HA-Nur77, encoding the HA-tagged Nur77 was transfected alone or was cotransfected with the PML expression plasmid pCDNA3/PML into the U2OS cells. Immuno¯uorescence staining was performed using the anti-HA monoclonal antibody. The results presented in Figure 6a showed that the HA-tagged Nur77 protein was localized in the nucleus in a nuclear-diused staining pattern, a ®nding consistent with the results reported previously. However, when the expression plasmid encoding the HA-tagged Nur77 was cotransfected with pCDNA3/PML, the HA-tagged Nur77-speci®c signals were nuclear-speckled, a staining pattern typical of PML. We repeated the cotransfection experiment using the control plasmid encoding the HAtagged alone and pCDNA/PML and found no such nuclear-speckled staining pattern (data not shown). This ®nding indicates that PML interacts and recruits The GST-PML fusion proteins were immobilized on the glutathione-Sepharose beads and pull-down assay was done as described above Figure 4 Eects of PML and its mutants on Nur77 transactivation function. U2OS cells were transiently cotransfected with the expression plasmids encoding PML and the PML mutants with pRC/Nur77, along with the reporter plasmid pGL3(NurRE)3-tkLuc. Luciferase activity was determined 24 h after transfection. The luciferase activities were normalized to b-galactosidase activity expressed from a cotransfected plasmid. The histogram represents the average of three independent sets of transfection experiments with error bars indicating one s.d.
Nur77 to the PML nuclear bodies in vivo in the cotransfection experiment.
To further investigate the in vivo association between PML and Nur77, we examined whether the two proteins are colocalized at the endogenous level by double immuno¯uorescence staining and confocal microscopic analysis. In this study SiHa cells were treated with TPA and interferon to induce the expression of Nur77 and PML, respectively. To overcome the background problem due to high expression of Nur77 throughout the nucleus and the cytoplasm after induction with TPA, cells were pretreated with cytoskeleton stripping buer as described by Mirzoeva and Petrini (2001) before ®xation to remove signals associated with the cytoplasm and the nucleoplasm. After such treatment Nur77 colocalizes with the tightly bound nuclear matrix associated PML NB are expected to remain intact. Result presented in Figure 6b represents a single section of a total of 26 thin sections of the confocal microscopic images. This study demonstrated that a signi®cant number of the Nur77 staining signals were found to colocalize with the PML NB at the endogenous level. This analysis shows that only some of the Nur77 signals are colocalized with the PML NB. Colocalization of the two proteins was not found in about 30 ± 50% of the cells. In addition, colocalization was found in dierent sizes of the PML NB. This ®nding supports a functional interaction between PML and Nur77 in vivo.
PML enhances Nur77-dependent apoptosis induced by TPA
To study the functional signi®cance of PML/Nur77 association in vivo, we investigated the eects of PML on Nur77-dependent apoptosis induced by 12-o-tetradecanoylphorbol-13-acetate (TPA) in the prostate cancer cell line LNCaP (Uemura et al., 1998; Li et al., 2000a) . It was reported previously that TPAinduced apoptosis in LNCaP is Nur77-dependent. Expression of an antisense Nur77 mRNA inhibited Nur77 expression and abolished the eect of TPA to induce apoptosis . In the present study, LNCaP cells treated or untreated with TPA were infected with the recombinant PML adenovirus (Ad-PML) and the negative control, as we described previously (Le et al., 1998) . Consistent with the results of the previous report, the present results showed that Ad-PML and TPA each separately induced a signi®cant degree of apoptosis in LNCaP cells. The combined eects of Ad-PML and TPA increased cell death to a level four times higher than that with Ad-PML or TPA alone (Figure 7 ). This ®nding indicates that PML enhances Nur77-dependent cell death induced by TPA and demonstrates a functional link between the two proteins in vivo.
Discussion
Results of the current study demonstrate that PML functionally and physically interacts with Nur77 and represses Nur77-mediated transactivation of NurRE. This study shows that PML dramatically inhibited the transactivation function of Nur77. PML does not bind directly to the NurRE but inhibits Nur77 from binding to NurRE by interacting with the DNA-binding domain and prevent it from binding to NurRE. Interaction between PML and Nur77 was further supported by GST pull-down assays that showed the in vitro-translated PML protein interacts with GSTNur77. Coimmunoprecipitation and cellular colocalization of the two proteins demonstrated the in vivo association between PML and Nur77. More importantly, our study showed that PML colocalized with Nur77 in SiHa cells at the endogenous level. Together, these results demonstrated that these two proteins are functionally associated with each other in vivo. Our study further showed that PML mutants that lacked the coiled-coil motif failed to bind to Nur77 and were unable to repress Nur77-mediated transactivation, indicating that the coiled ± coil dimerization domain of PML is required for interacting with Nur77 and for the repression of transcription. Our study further showed that the DNA-binding domain of Nur77 is responsible for interacting with PML.
Nur77 colocalized with the PML NB when U2OS cells were cotransfected with the two expression plasmids, indicating that PML interacts with Nur77 in vivo and recruits Nur77 to the PML NB. Although the exact role of the PML NB remains unknown, Figure 5 PML interferes with the DNA binding of Nur77 to NurRE. The electrophoretic mobility shift assay was performed using in vitro-synthesized proteins, as described in Materials and methods. In vitro translated Nur77 (1 ml) was preincubated with increasing concentrations of the in vitro-synthesized PML (1 ± 4 ml, lanes 3 ± 6). The binding reaction was competed by the addition of 50 molar excesses of cold oligonucleotides (lane 7). Anti-Nur77 antibody was included in a supershift assay (lane 8). After the preincubation, reaction mixtures were incubated with 32 P-labeled NurRE and analysed in a 5% native polyacrylamide gel recent studies suggest that this macronuclear structure is a multi-protein complex that plays a role as storage sites or a reservoir for cellular regulatory proteins. SUMO-1 modi®cation of PML is required for recruiting proteins to the NB. This process is believed to play a role in regulating protein stability (Seeler and Dejean, 2001 ). Since transcription factors have been shown recruited to the NB, this nuclear structure may serve as a site for these proteins to assemble and modify under appropriate conditions. Many viral proteins interact with PML and some disrupt the integrity of the PML NBs and recruit essential proteins factor to the viral replication origin (Maul, 1998; Everett, 2001) . This support PML NB as storage sites for important cellular regulatory proteins. Colocalization of PML and Nur77 in the NB at the endogenous level implies that PML NB plays a role in regulating Nur77 transactivation of its target genes. Whether PML NB is the actual site of transcriptional activation remains disputable (Lin et al., 2001) . Results presented in Figures 2, 5 , and 6, demonstrated that PML interacts with the DNA-binding domain of Nur77 in vitro and in vivo and prevents it from binding to the NurRE. Based on this ®nding we hypothesize that PML represses Nur77-mediated transcription by a mechanism involving sequestration of Nur77 to the PML NB and restricts its availability from the site of NurRE.
PML is a growth suppressor that represses cell growth and promotes cell death (Le et al., 1998; Mu et al., 1994 Mu et al., , 1997 . It is clear that PML's function is essential for multiple pathways of apoptosis (Wang et al., 1998; Quignon et al., 1998) , however, the mechanism of how PML induces apoptosis is not clear. PML induces p53 and p21 expression, downregulation of cyclin D1, and induces hypophosphorylation of Rb. These events are associated with PML's ability to induce a cell cycle arrest at G1 phase of the (Le et al., 1998; Mu et al., 1997) . Recent studies demonstrated that PML is functionally associated with p53 tumor suppressor and plays a role in Ras-induced cellular senescence (Pearson et al., 2000; Ferbeyre et al., 2000) . Furthermore, p53 protein was recruited to the PML NB, and enhanced p53 transactivation and its growth suppressor functions (Fogal et al., 2000) . Another recent study identi®ed a PML-dependent p53-regulated pathway of apoptosis (Guo et al., 2000) . These studies further support a role of PML in cell cycle regulation and apoptosis.
Nur77 plays an important role in negative selection of antigen presenting cells during thymocytes development (Amsen et al., 1999) . T-cell receptor triggers apoptosis in thymocytes induces rapid expression of Nur77 Woronicz et al., 1994) . Overexpression of Nur77 in thymocytes induced massive apoptosis in transgenic mice (Weih et al., 1996) . Expression of a dominant negative mutant of Nur77 inhibits apoptosis and impaired negative selection of antigen presenting cells in thymocytes (Calnan et al., 1995) . It is not clear whether PML plays a role in regulation of Nur77 function in thymocytes, however, a role of PML as an anti-in¯ammatory protein has been documented. A signi®cant induction of PML expression can be achieved by treatment with interferon, ionizing radiation and other DNA damaging agents (Melnick and Licht, 1999) supporting a role of PML in host cells defense. Interestingly, our study here showed that Nur77-mediated apoptosis induced by TPA in the LNCaP cell line was four times higher when PML was overexpressed (Figure 7) , indicating synergy between the two proteins in mediating apoptosis. The ability of Nur77 to induce apoptosis in LNCaP cells is independent from its function in transactivation (Li et al., 2000a) . After TPA induction, the GFP-tagged Nur77 was found quickly translocated to the mitochondria, and induces apoptosis by triggering the release of cytochrome c. However, it is not known whether TPA induces the endogenous Nur77 in LNCaP cells to translocate to the mitochondria. In our endogenous colocalization experiment, we found a signi®cant increase in Nur77 staining signals after TPA induction that are widely distributed throughout the nucleus and the cytoplasm in SiHa cells (Figure 6b ). PML and Nur77 were found to colocalize in the nucleus in a signi®cant number of cells pretreated with the stripping buer (Figure 6b ). It is possible that at the endogenous level, TPA induced Nur77 translocation to the mitochondria and induced apoptosis through the release of cytochrome c. In cells overexpressing PML after interferon induction, Nur77 may interact with PML in the nucleus and induce apoptosis through a yet unknown mechanism. The mechanism whereby PML cooperates with Nur77 to promote cell death remains to be elucidated.
Materials and methods
Cell culture
U2OS, 293T cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum.
Plasmid constructs
The NurRE-tk-Luc reporter was constructed by inserting the NurRE synthetic oligonucleotide into the SmaI and BglII sites of pGL3-basic vector. The pCruz-HA/Nur77 expression plasmid was constructed by subcloning the 1.8 kb PCRampli®ed full-length cDNA of Nur77 into the EcoRI/XbaI sites of the expression vector pCruz-HA-A. The pRC/CMV2-Nur77 expression plasmid was created by subcloning the HindIII/XbaI fragment of pBS-Nur77 into the pRC/CMV2 vector. The pCDNA3-His/PML expression plasmid and its mutants were constructed as described in our previous report (Wu et al., 2001) . The PML expression plasmids pcDNA3/ PML and pRC/E2F1 were obtained as described previously (Vallian et al., 1998a) . The Nur77 mutant expression plasmids pCruz-Nur77(1 ± 275), pCruz-Nur77(1 ± 345), pCruz-Nur77(260 ± 601), and pCruz-Nur77(333 ± 601) were constructed by PCR-ampli®cation of the respective regions of pCruz-HA/Nur77 and subcloned into the pCruz-HA-A vector. Correct DNA sequences of each clone were con®rmed by DNA sequencing.
Preparation of Nur77, PML and PML mutant proteins and nuclear extracts
Nur77 and PML proteins were synthesized in vitro by the TNT Quick Coupled Wheat Germ Transcription/Translation system (Promega Corp, Madison, WI, USA) as described previously (Vallian et al., 1998b) . The amounts of the in vitrotranslated proteins were determined by 35 S-methionine incorporation and analysed in a sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS ± PAGE), and the amount of incorporated radioactivity was quantitated. Nuclear extracts from cells transfected with the expression plasmids were prepared as follows: Cells transfected with pCruzHA/Nur77 were washed twice with Tris-buered saline (TBS) (20 mM Tris-HCl, pH 7.5, 100 mM NaCl), removed from the dish, placed into ice-cold TBS and collected by centrifugation. The cell pellet was resuspended in 0.6 ml of hypotonic buer (containing 25 mM Tris-HCl (pH 7.4), 1 mM MgCl 2 , and 5 mM KCl) and left on ice for 5 min. An equal volume of hypotonic buer containing 1% NP-40 was then added, and the cells were incubated on ice for an additional 5 min. Cell lysate was then centrifuged at 5000 g for 5 min. The supernatant containing the cytoplasmic fraction was removed and the nuclei were resuspended in 100 ml of nuclear resuspension buer (20 mM HEPES (pH 7.9), 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1% aprotinin and 1 mM PMSF). The nuclear extracts were incubated with sharking at 48C for 30 min and clari®ed by centrifugation at 12 000 g for 10 min.
Luciferase reporter gene assays
Transfection of expression plasmids was performed in 12-well plates with Fugene 6 (Roche Diagnostics Corp., Nutley, NJ, USA) using 10 4 exponentially growing U2OS cells. Cells were grown in DMEM with 10% fetal calf serum and harvested 16 h post-transfection. Each transfection assay contained a total of 1 mg of DNA, including 100 ng of reporter plasmid, 50 ng of pRC/CMV2-Nur77 expression plasmid, 50 ng of bgalactosidase expression plasmid and various amounts of PML and its mutants. The pCDNA3 plasmid DNA was added to increase the total DNA content in each assay to 1 mg. Transfected cells were harvested and luciferase activity was determined 24 h after transfection. Results are presented as luciferase activity and normalized for transfection eciency according to the b-galactosidase activity.
Gel retardation assay
Double-stranded oligonucleotide (5'-GATCCTAGTGA-TATTTACCTCCAAATGCCAGGA-3') of NurRE primers were labeled at the 3'-end with Klenow polymerase and puri®ed by Qiaquick Nucleotide Removal Kit (QIAGEN Inc., Valencia, CA, USA). The DNA binding assay was performed by incubating the in vitro-translated PML and Nur77 proteins with the 32 P-labeled oligonucleotides (20 ml reaction mixture containing 10 mM HEPES, pH 7.9, 50 mM KCl, 2.5 mM MgCl 2 , 1 mM dithiothreitol, 0.05% NP-40, 5% glycerol and 500 ng of poly(dI-dC)) at 258C for 30 min. In order to maintain an equal protein concentration in all reaction mixtures, unprogrammed wheat germ lysate was added. Each reaction mixture was then loaded on a 5% nondenaturing polyacrylamide gel containing 0.256TBE buer.
GST pull-down assay
To prepare the glutathione-s-transferase (GST)-Nur77 and GST-PML fusion proteins, the Nur77 and PML cDNA were subcloned in frame into the pGEX-2T vector and used to transform Escherichia coli BL21 hosts. GST fusion proteins were prepared as previously described (Wu et al., 2001) . To reduce nonspeci®c background binding, glutathione agarose beads were preincubated with bovine serum albumin (2 mg/ ml) and soluble protein (2 mg/ml) extracted from E. coli BL21. Equal quantities of GST-fusion proteins and GST were incubated with the 35 S-labeled in vitro-translation proteins at 48C for 16 h, in 500 ml of buer (50 mM HEPES (pH 7.9), 150 mM NaCl, 0.5% NP-40, 0.03% SDS, 100 mM NaF and 10 mM PMSF). After being washed ®ve times with PBS containing 1% NP-40 and 0.05% SDS, the bound proteins were analysed by 8% SDS ± PAGE.
Immunofluorescence staining and microscopic analysis U2OS cells were grown on coverslips and ®xed for 30 min in 4% paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100, and processed for immuno¯uorescence staining as previously described (Le et al., 1998) . Cells were incubated with the primary anti-HA monoclonal antibody that recognizes the HA-tagged Nur77 and then stained with goat antimouse-IgG-FITC secondary antibody (Roche Inc). For endogenous colocalization study, SiHa cells were treated with TPA and interferon-a to induce the expression of Nur77 and PML respectively. Double color immuno¯uorescence staining was performed using PML monoclonal antibody (PG-M3, Santa Cruz Biotech Inc) and Nur77 polyclonal antibody (M210, Santa Cruz Biotech Inc) as described above with the exception that before ®xation, cells were pretreated with cytoskeleton stripping buer according to the procedure described by Mirzoeva and Petrini (2001) . Images were captured with a Zeiss laser scan confocal microscope (LSM 5).
Co-immunoprecipitation
293T cells were transiently cotransfected with pCruzHA/ Nur77 and pCDNA3/PML expression vector. The nuclear extract was preincubated with nonspeci®c pre-immune serum and protein-G agarose beads for 3 h on ice. After centrifugation, the supernatant was incubated with anti-HA monoclonal antibody for 4 h at 48C. Protein-G agarose was added and the mixture was incubated for 1 h. Antibody complexes were pelleted and washed three times with TBS containing 0.25% NP-40 and 0.03% SDS. Pellets were resuspended in loading buer and analysed by SDS ± PAGE and immunoblotting using anti-PML antibody.
